YARS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.316390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.365600E-01
Normal-vs-Stage2
1.109610E-01
Normal-vs-Stage3
9.244000E-01
Normal-vs-Stage4
2.615800E-01
Stage1-vs-Stage2
8.033200E-01
Stage1-vs-Stage3
9.709800E-01
Stage1-vs-Stage4
2.720600E-01
Stage2-vs-Stage3
8.033000E-01
Stage2-vs-Stage4
2.577200E-01
Stage3-vs-Stage4
4.502600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.009800E-01
Normal-vs-AfricanAmerican
5.557200E-01
Normal-vs-Asian
5.932200E-01
Caucasian-vs-AfricanAmerican
3.395400E-01
Caucasian-vs-Asian
8.812800E-01
AfricanAmerican-vs-Asian
3.992400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.633400E-01
Normal-vs-Female
1.163760E-01
Male-vs-Female
5.884600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.597400E-01
Normal-vs-Age(41-60Yrs)
2.405600E-02
Normal-vs-Age(61-80Yrs)
7.083000E-01
Normal-vs-Age(81-100Yrs)
1.178430E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.593400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.714800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.871200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.836000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.312600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.726400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.554200E-01
Normal-vs-Daily Drinker
7.855200E-01
Normal-vs-Weekly Drinker
4.685600E-01
Normal-vs-Occasional Drinker
2.301800E-01
Normal-vs-Social Drinker
5.070800E-01
Non Drinker-vs-Daily Drinker
8.003200E-01
Non Drinker-vs-Weekly Drinker
7.685600E-01
Non Drinker-vs-Occasional Drinker
1.162360E-01
Non Drinker-vs-Social Drinker
7.493800E-01
Daily Drinker-vs-Weekly Drinker
6.666200E-01
Daily Drinker-vs-Occasional Drinker
1.259240E-01
Daily Drinker-vs-Social Drinker
6.294000E-01
Weekly Drinker-vs-Occasional Drinker
3.587600E-01
Weekly Drinker-vs-Social Drinker
9.260800E-01
Occasional Drinker-vs-Social Drinker
5.605200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.921800E-01
Normal-vs-Grade 2
7.830600E-01
Normal-vs-Grade 3
3.396800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.147800E-02
Grade 1-vs-Grade 3
2.134300E-02
Grade 1-vs-Grade 4
8.921800E-01
Grade 2-vs-Grade 3
1.050960E-01
Grade 2-vs-Grade 4
7.830600E-01
Grade 3-vs-Grade 4
3.396800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.834400E-01
Normal-vs-NonDiabetic
1.359780E-01
Diabetic-vs-NonDiabetic
6.373800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.861400E-01
Normal-vs-NoPancreatitis
2.320400E-01
Pancreatitis-vs-NoPancreatitis
4.126200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.021400E-01
Normal-vs-N1
1.504610E-01
N0-vs-N1
8.005200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.343300E-03
Normal-vs-TP53-NonMutant
4.893200E-01
TP53-Mutant-vs-TP53-NonMutant
9.976300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
